NCT01983358View on ClinicalTrials.gov

The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Stroke
Interventions
DRUG

JPI-289

PARP-1 inhibitor

OTHER

Placebo

Placebo

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY

NCT01983358 - The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers | Biotech Hunter | Biotech Hunter